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Key points
 Resistance exercise training (RET) is one of the most effective strategies for preventing declines
in skeletal muscle mass and strength with age.
 Hypertrophic responses to RET with age are diminished compared to younger individuals.
 In response to 6weeksRET,we foundbluntedhypertrophic responseswith age are underpinned
by chronic deficits in long-term muscle protein synthesis.
 We show this is likely to be the result of multifactorial deficits in anabolic hormones and
blunted translational efficiency and capacity.
 These results provide great insight into age-related exercise adaptations and provide a platform
on which to devise appropriate nutritional and exercise interventions on a longer term basis.
Abstract Ageing is associatedwith impairedhypertrophic responses to resistance exercise training
(RET). Here we investigated the aetiology of ‘anabolic resistance’ in older humans. Twenty
healthy male individuals, 10 younger (Y; 23 ± 1 years) and 10 older (O; 69 ± 3 years), performed
6 weeks unilateral RET (6 × 8 repetitions, 75% of one repetition maximum (1-RM), 3 times per
week). After baseline bilateral vastus lateralis (VL) muscle biopsies, subjects consumed 150 ml
D2O (70 atom%; thereafter 50mlweek−1), further bilateral VLmuscle biopsieswere taken at 3 and
6 weeks to quantify muscle protein synthesis (MPS) via gas chromatography–pyrolysis–isotope
ratiomass spectrometry.AfterRET, 1-RMincreased inY(+35±4%)andO(+25±3%;P<0.01),
while MVC increased in Y (+21 ± 5%; P < 0.01) but not O (+6 ± 3%; not significant (NS)). In
comparison toY,OdisplayedbluntedRET-induced increases inmuscle thickness (at 3 and6weeks,
respectively, Y: +8 ± 1% and +11 ± 2%, P < 0.01; O: +2.6 ± 1% and +3.5 ± 2%, NS). While
‘basal’ longer term MPS was identical between Y and O (1.35 ± 0.1% day−1), MPS increased
in response to RET only in Y (3 weeks, Y: 1.61 ± 0.1% day−1; O: 1.49 ± 0.1% day−1). Consistent
with this, O exhibited inferior ribosomal biogenesis (RNA:DNA ratio and c-MYC induction: Y:
+4 ± 2 fold change; O: +1.9 ± 1 fold change), translational efficiency (S6K1 phosphorylation,
Y: +10 ± 4 fold change; O: +4 ± 2 fold change) and anabolic hormone milieu (testosterone, Y:
367 ± 19; O: 274 ± 19 ng dl−1 (all P < 0.05). Anabolic resistance is thus multifactorial.
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Introduction
Advancing age is associated with incipient declines in
skeletal muscle mass, strength and quality, processes
termed sarcopenia and dynapenia (Mitchell et al. 2012).
Since skeletal muscles are central for locomotion and the
performance of everyday habitual activities, declines in
muscle mass and function lead to impaired quality of
life and independence. Furthermore, as skeletal muscle
plays a substantial role in whole body metabolic health,
muscle loss results in decreased metabolic rate (Tzankoff
&Norris, 1977) and increased risk ofmorbidity (Luukinen
et al. 1997) and mortality (Laukkanen et al. 1995). With
increases in life expectancy showing no signs of slowing
(Christensen et al. 2009) and those> 60 years predicted to
represent 25%of the population by 2050, increased strains
on the healthcare system are expected to rise (Janssen et al.
2004).
Muscle mass is controlled by the diurnal balance
between muscle protein synthesis (MPS) and muscle
protein breakdown (MPB) (Atherton & Smith, 2012).
Therefore, declines inmass occur whenMPS is chronically
lower than MPB. On a diurnal basis, the most significant
regulators of MPS and MPB are food intake (in particular
protein; Atherton et al. 2010; Bukhari et al. 2015;
Wilkinson et al. 2015) and physical activity (Kumar et al.
2009a, 2012; Breen et al. 2013; Wilkinson et al. 2014).
Both feeding and exercise transiently stimulate MPS, and
when combined result in sustained positive net balance
and eventually protein accretion, i.e. following a resistance
exercise training (RET) programme (Phillips et al. 1997;
Moore et al. 2009, 2015; Fry et al. 2011; Bukhari et al.
2015). Whilst basal rates of MPS and MPB are not
detectably lower in old age (Volpi et al. 2001; Kumar et al.
2009b), older individuals do exhibit ‘anabolic resistance’,
manifesting as a reduced anabolic response to these key
growth signals regulating homeostasis (Cuthbertson et al.
2005; Kumar et al. 2009b; Fry et al. 2011; Wall et al. 2015).
Over time, inadequate replenishment of muscle protein
lost during fasting or inactivity leads to a progressive loss
of muscle with age.
RET arguably offers the most effective countermeasure
and lowest risk profile strategy to mitigate age-related
declines in skeletal muscle mass and strength (Fiatarone
et al. 1994). However in response to the same RET
programme, older individuals generally show attenuated
muscle hypertrophy (Welle et al. 1996; Kosek et al. 2006;
Greig et al. 2011; Peterson et al. 2011; Mero et al.
2013), although equal adaptations have been reported
(Ha¨kkinen et al. 1998b; Mayhew et al. 2009). The exact
mechanisms leading to RET-induced anabolic resistance
are unclear. Ageing can be associated with neuromuscular
deficits (e.g. loss of motor units; Campbell et al. 1973),
sustained malnutrition (Morley, 2012), physical inactivity
(Troiando et al. 2008), suboptimal anabolic hormonal
profiles (Feldman et al. 2002) and various co-morbidities
and chronic diseases (Marengoni et al. 2011), all of
which theoretically represent unfavourable attributes
for hypertrophy. Additionally at the cellular level,
muscle signalling responses linked with increased trans-
lational efficiency (e.g. mechanistic target of rapamycin
complex 1 (mTORC1) signalling) and capacity (ribosomal
biogenesis) have been shown to be blunted ‘acutely’ with
ageing (Kumar et al. 2009a; Fry et al. 2011; Stec et al.
2015). Nonetheless, the coordinate mechanisms remain
elusive and are likely to be multifactorial in nature.
Current assumptions on the mechanisms of muscle
hypertrophy in youth and ageing have been largely derived
from ‘acute’ metabolic and molecular studies, i.e. those
undertaken after a single bout of resistance exercise
(RE)(Miller et al. 2005; Kumar et al. 2009b; Fry et al. 2011;
Bukhari et al. 2015). Nonetheless, due to the disparity
in acquisition of these acute response, i.e. nutritional
provision, length ofmeasurement and exercise paradigms,
the exact relationships between acute responses and
blunted adaptations are unclear (Mitchell et al. 2014;
Atherton et al. 2015). Similar issues are associated with
RET studies where hypertrophic adaptations are assessed
with a single beginning and end-point (Ha¨kkinen et al.
1998b; Mayhew et al. 2009) in which physiological
insight is great but metabolic and molecular insight is
limited. To circumvent these limitations, we quantified
MPS responses to 6 weeks RET in young and older
individuals using novel heavy water, deuterium oxide
(D2O) techniques (Robinson et al. 2011; Wilkinson et al.
2014); simultaneously we temporally assessed indices of
cellular translational efficiency and capacity. We hypo-
thesized that following 6 weeks of RET, skeletal muscle
hypertrophy would be blunted with age, primarily due to
long-term deficits in cumulative MPS responses with the
underlying mechanisms multifactorial.
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Methods
Subject characteristics and ethics
Ten healthy younger (23 ± 1 years, BMI: 24 ± 1)
(Brook et al. 2015) and older (69 ± 1 years, BMI
25.8 ± 1) men were recruited. Volunteers were screened
by medical questionnaire, physical examination, and
resting electrocardiogram, with exclusions for metabolic,
respiratory and cardiovascular disorders or any other
symptoms of ill health. Subjects had clinically normal
blood chemistry, were normotensive (<140/90), and were
not prescribed any medications: all subjects performed
activities of daily living and recreation but did not under-
take in any RET other than that described in the study
and had not participated in any RET within the last
12 months. All subjects provided their written, informed
consent to participate after all procedures and risks (in
relation to muscle biopsies, blood sampling, etc.) were
explained. This study was approved by The University of
NottinghamEthics Committee, with all studies conducted
according to the declaration of Helsinki and preregistered
(clinicaltrials.gov registration no. NCT02152839).
Conduct of the study
This study involved a bilateral (i.e. two legged) protocol
whereby one leg was used as an untrained (UT) inter-
nal time control with the other leg acting as the RET
(trained; T) leg, with the dominant leg assigned as T.
Following inclusion to the study, subjects were studied
over a 6-week period. On the first day of study, subjects
arrived at the laboratory at 08.30 h following an overnight
fast. Following assessment of vastus lateralis (VL) muscle
architecture by ultrasound (Mylab 70; Esaote Biomedica,
Italy) and body composition by dual energy X-ray
absorptiometry (DXA; Lunar Prodigy II, GE Medical
Systems, Little Chalfont, UK), subjects completed the first
session of RET consisting of unilateral knee-extension
exercise (i.e. 6 × 8 repetitions at 75% of one repetition
maximum (1-RM)). Bilateral biopsies were taken from the
VLmuscle 60–90min (75± 2min) after unilateral exercise
under sterile conditions, using the conchotome biopsy
technique (Dietrichson et al. 1987) with 1% lidocaine (B.
Braun, Melsungen, Germany) as local anaesthetic. Muscle
was rapidly dissected free of fat and connective tissue,
washed in ice-cold phosphate-buffered saline (PBS), and
then frozen in liquid N2 and stored at –80°C until further
analysis. Immediately post-RET, subjects provided a saliva
sample (collected in sterile plastic tubes) and consumed a
150 ml bolus of D2O (70 atom%; Sigma-Aldrich, Poole,
UK), with the aim to label the body water pool to
0.2% atom percent excess (APE), which was maintained
in a pseudo-steady state with weekly top-up boluses
(50 ml week−1). In addition, venous blood samples were
collected into lithium heparin coated tubes, immediately
cold centrifuged at 1750 g, with plasma fractions aliquoted
and frozen at –80°C until analysis. Thereafter, subjects
returned to the lab 3 times per week to undertake super-
vised unilateral RET with 1-RM assessments of the T leg
every 10 days to ensure progressive intensity. Further
bilateral muscle biopsies (90 min after RET in order to
investigate the temporal nature of acute anabolic signalling
responses to progressive RET), ultrasound measures of
muscle architecture and venous blood samples were taken
at 3 and 6 weeks and DXA performed at 6 weeks.
For the temporal monitoring of body water enrichment,
each participant provided a saliva sample on RET-visits
> 30 min after their last meal or drink, with extra
samples taken 3 h after weekly 50 ml boluses to ensure
body water enrichment was accurately represented. These
were collected in sterile plastic tubes and immediately
cold-centrifuged at 16,000 g to remove any debris that
might be present; they were then aliquoted into 2 ml
glass vials and frozen at –20°C until analysis. To measure
levels of physical activity, subjects wore combined heart
rate and activity monitors (Actiheart, CamMtech Ltd,
Cambridge, UK) for 1 week during the study. Actiheart
data were checked for missing or extrapolated values;
 80% of minute-by-minute physical activity data had
to be available for a 24 h recording to be accepted,
85% of subjects had at least  4 days of data with the
remaining having 1 day of data that were included in the
analysis. Dietary intake was monitored by completion of
4-day diet diaries during the study and was analysed using
Microdiet (Downlee Systems Ltd, Chapel-en-le-Frith,
UK). A detailed representative schematic diagram of the
study protocol in its entirety is depicted in Fig. 1.
Muscle functional tests
Basal measures of maximal voluntary contraction (MVC)
and 1-RM were ascertained in the week prior to the first
study day. MVC was measured with isometric contra-
ctions conducted in a sitting position using an iso-
kinetic dynamometer (Isocom; Isokinetic Technologies,
Eurokinetics, UK) over a range of four knee joint angles
(90–60 deg), with full extension corresponding to 0 deg.
Subjects were seated in the dynamometer chair and
secured into position using a chest strap. Contractions
lasted 4 s, with a 30 s rest period between contractions and
90 s between knee joint angles. Unilateral leg extension
1-RM was assessed on the dominant leg (Technogym,
Gambettola, Italy). After the procedure was explained,
subjects performed a light warm up to avoid injury and
ensure familiarity whilst avoiding fatigue; 1-RM was then
achieved (20 on Borg’s rating of perceived exertion scale)
in as few repetitions as possible with a maximum of five
repetitions. The first repetition was estimated at 50%
1-RMand then increaseduntil subjects couldnot complete
controlled contraction throughout the range of motion,
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
7402 M. S. Brook and others J Physiol 594.24
with 3 min in-between attempts. Functional tests were
repeated throughout (about every10days),with each set of
tests performed on a non-biopsy day to avoid influencing
subsequent measures.
Muscle architecture and DXA derived mass
Muscle architecture was measured as described (Franchi
et al. 2014). Briefly, the architectural parameters muscle
thickness (MT), fibre length (Lf) and pennation angle (θ)
were quantified, by the same ‘blinded’ investigator (M.B.),
from ultrasound scans using ImageJ 1.42q (National
Institutes of Health, Bethesda, MD, USA). The visible
portion of the Lf was assessed directly using this software
with MT measured as the distance between the super-
ficial and deep aponeuroses. θ was measured as the inter-
sectionbetween fascicles and thedeep tendonaponeurosis.
DXA-derived thigh fat-free mass (TFFM) was determined
from the lowest point of the ischium to the knee space.
Body water and protein bound alanine muscle
fraction enrichment
Bodywater andmuscle protein enrichmentweremeasured
as previously described (Wilkinson et al. 2014). Briefly,
pure fractions of body water were extracted by heating
100 μl of saliva in an inverted 2 ml autosampler vial for
4 h at 100°C. Vials were then placed upright on ice to
condense extracted body water and transferred to a clean
autosampler vial ready for injection. Body water (0.1 μl)
was injected into ahigh-temperature conversion elemental
analyser (Thermo Finnigan, Thermo Scientific, Hemel
Hempstead, UK) connected to an isotope ratio mass
spectrometer (Delta V Advantage, Thermo Scientific).
For isolation of myofibrillar protein, 30–50 mg of
muscle was homogenized in ice-cold homogenization
buffer (Wilkinson et al. 2014), rotated for 10 min,
and the supernatant was collected after centrifugation
at 13,000 g for 5 min at 4°C. The myofibrillar pellet
was solubilized in 0.3 M NaOH and separated from
the insoluble collagen by centrifugation, and the myo-
fibrillar protein was precipitated using 1 M perchloric
acid (PCA). Sarcoplasmic proteins were precipitated from
the sample homogenate with 1 M PCA and separated by
centrifugation. Protein-bound amino acids were released
using acid hydrolysis by incubating at 110°C in 0.1 M
HCl in Dowex H+ resin slurry overnight before being
eluted from the resin with 2 M NH4OH and evaporated
to dryness; amino acids were then derivatized as their
n-methoxycarbonyl methyl esters. Dried samples were
suspended in 60 μl distilled water and 32 μl methanol,
and following vortex, 10 μl of pyridine and 8 μl of
methylchloroformate were added. Samples were vortexed
for 30 s and left to react at room temperature for
5 min. The newly formed n-methoxycarbonyl methyl
esters of amino acids were then extracted into 100 μl
of chloroform. A molecular sieve was added to each
sample for 20 s before being transferred to a clean glass
Gas Chromatography insert, removing any remaining
water by size exclusion absorption. Incorporation of
deuterium into protein bound alanine was determined
by gas chromatography–pyrolysis–isotope ratio mass
0Week 1 2 3 4 5 6
D2O (70AP)
Unilateral RE
Saliva
Muscle Biopsy
Venous Blood
Ultrasound
DXA
UT
T
 4 day diet diary + 1 week activity monitoring
3.wk−1
3.wk−1 (6 × 8 repetitions at 75% 1-RM)
150ml 50ml 50ml 50ml 50ml 50ml 50ml
Figure 1. Schematic diagram of study protocol
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spectrometry (Delta V Advantage) alongside a standard
curve of known L-alanine-2,3,3,3-d4 enrichment to
validate measurement accuracy of the instrument.
Calculation of fractional synthetic rate
Myofibrillar MPS was calculated from incorporation
of deuterium-labelled alanine into protein, using the
enrichment of bodywater (corrected for themeannumber
of deuterium moieties incorporated per alanine, 3.7, and
the dilution from the total number of hydrogens in the
derivative, i.e. 11) as the surrogate precursor labelling
between subsequent biopsies. Fractional synthetic rate
(FSR) is as follows:
FSR = −ln
⎛
⎝−1
[
(APEAla)
(APEP)
]
t
⎞
⎠ ,
where APEAla is deuterium enrichment of protein-bound
alanine, APEP ismean precursor enrichment over the time
period, and t is the time between biopsies. Thigh absolute
synthetic rate was calculated as:
ASR = FSR
100
× TFFM × (ASP)
100
,
where TFFM is thigh fat-free mass derived by DXA and
alkali soluble protein (ASP) is the average soluble protein
over the 6 weeks. Absolute protein breakdown rate (ABR)
was calculated as:
ABR = FBR
100
× TFFM × (ASP)
100
,
where fractional breakdown rate (FBR) is calculated
as FBR = FSR − FGR, with the fractional growth rate
(FGR) assumed to be linear over 6 weeks. Using a linear
growth rate takes into account the average adaptation in
growth and turnover rates over the 6 weeks; however,
this limits the ability to investigate temporal changes in
absolute rates.
Muscle protein, DNA and RNA concentrations
(translational efficiency/capacity)
To determine muscle alkaline soluble protein, DNA and
RNA concentrations (per mg dry weight), 15 mg
muscle tissue was freeze dried. Dry tissue was homo-
genized in 0.2 M PCA. Following centrifugation at
11,680 g and washing with 0.2 M PCA, the resulting
pellet was resuspended in 0.3 M NaOH and alkali
soluble proteins were quantified by spectrophotometry
(NanoDrop Lite, Thermo Scientific). Thereafter proteins
were precipitated with 1 M PCA before centrifugation
and removal of the supernatant for RNA quantification
by UV spectrophotometry. The remaining pellet was
resuspended in 2 M PCA and incubated at 70°C for 1 h
before centrifugation and removal of the supernatant for
quantification of DNA by spectrophotometry (Laurent
et al. 1978; Smith et al. 2011).
Immunoblotting for Akt–mTORC1 signalling
components and ELISA
Immunoblotting was performed on VL muscle
sarcoplasmic fractions with protein concentrations
determined by spectrophotometry (NanoDrop Lite);
samples were standardized to 1 mg ml−1 by dilution
with 3× Laemmli loading buffer and heated at 95°C
for 5 min. Precisely 15 μg of proteins were loaded onto
Criterion XT Bis–Tris–12% SDS-PAGE gels (Bio-Rad) for
electrophoresis at 200 V for 1 h. As previously described
(Atherton et al. 2009; Crossland et al. 2013) samples
were transferred to polyvinylidene difluoride membranes
for 45 min at 100 V. Membranes were subsequently
blocked in 2.5% low-fat milk (diluted in Tris-buffered
saline and 0.1% Tween-20 (TBS-T)) for 1 h at ambient
temperature and then incubated rocking overnight at
4°C in the presence of the following primary anti-
bodies: 30 mg primary antibodies (1:2000 dilution
in 2.5% BSA in TBS-T) against mechanistic target of
rapamycin (mTOR)Ser2448, totalmTOR, ribosomal protein
S6 kinase 1 (P70S6K1)Thr389, total P70S6K1, protein
kinase B (Akt)Ser473, total Akt, eukaryotic translation
initiation factor 4E-binding protein 1 (4EBP1)Thr37/46,
total 4EBP1, eukaryotic elongation factor 2 (eEF2)Thr56,
total eEF2, ribosomal protein S6 (rps6)ser240/244, total
rps6, Beclin-1, ERK 1/2Thr202/Tyr204 (New England Biolabs,
Hitchin, UK), Cathepsin L and calpain 1 (Abcam,
Cambridge, UK). For nuclear proteins, immunoblotting
was performed as above with muscle initially homo-
genized in RIPA buffer (Thermo Scientific) with 1 mM
EDTA, 1 mM activated Na3VO4 (Sigma-Aldrich) and a
completeprotease inhibitor cocktail tablet (Roche,Burgess
Hill, UK). Primary antibody concentrations were 1:2000
for retinoblastoma (pRB)S780 (New England Biolabs),
upstream binding factor 1 (UBF1)S484, total upstream
binding factor 1 (UBF1), total transcription initiation
factor 1 (TIF1a) (Abcam, Cambridge, UK) and 1:1000
for C-Myc (New England Biolabs) and transcription
initiation factor 1 (RRN3)S649 (Abcam). Membranes were
washed 3 × 5 min in TBS-T, incubated in horse-
radish peroxidase (HRP)-conjugated secondary anti-
body (New England Biolabs; 1:2000 in 2.5% BSA in
TBS-T) at room temperature for 1 h, before the last
3 × 5 min washes in TBS-T. Membranes were exposed
to Chemiluminescent HRP Substrate (Millipore Corp.,
Billerica, MA, USA) for 5 min and bands quantified
by Chemidoc MP (Bio-Rad, Hemel Hempstead, UK).
Software measures were taken to prevent pixel saturation.
Protein-loading anomalies were corrected to Coomassie
protein (Welinder & Ekblad, 2011); relative arbitrary
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units (RAU) were normalized to Coomassie-stained
membranes and subsequently normalized to the rest leg
at that specific time point. Plasma levels of testosterone,
IGF1 and myostatin were analysed in all O subjects
and nine Y subjects using enzyme-linked immuno-
sobent assays (ELISA) according to the manufacturer’s
protocol with the following commercially available kits:
GDF-8/Myostatin Quanitkine ELISA Kit (DGDF80, R&D
Systems, Abingdon, UK), Testosterone ELISA Kit (Abcam
ab108666) and IGF1Quantikine Elisa Kit (R&D DG100).
Gene expression analysis
Total RNA was isolated by homogenizing 5–10 mg of
muscle in 200 μl of TRizol (Life Technologies/Thermo
Fisher Scientific) using two stainless steel beads (Tissue
Lyser II, Qiagen, UK) for 1 min at 30 s–1. Samples
were placed at ambient temperature for 10 min before
80 μl of chloroform was added and samples vortexed
and incubated at ambient temperature for 10 min. After
centrifugation at 12,000 g for 15 min at 4°C the upper
aqueous layer was removed and RNA precipitated with
an equal volume of isopropanol, incubation at room
temperature for 10 min and subsequent centrifugation
at 7000 g for 10 min at 4 °C. The pellet was washed
twice with 1 ml of 80% ethanol, dissolved in 22 μl of
RNA-free water and quantified by spectrophotometry
(NanoDrop Lite). For RT-qPCR 500 ng of total RNA
was reversed-transcribed with the high-capacity cDNA
reverse transcription kit (Life Technologies) according to
the manufacturer’s protocol. Resulting cDNA was diluted
1:5 and 1 μl was added per well of 384-optical well plates
(Life Technologies). Exon specific primers were mixed
with SYBRSelectMasterMix (LifeTechnologies) and11μl
of master-mix was added to each well, with samples run
in triplicate. Thermal cycling conditions were 2 min at
50°C followed by 2 min at 95°C and 40 cycles of 15 s at
95°C and 60 s at 60°C on a ViiATM 7 Real-Time PCR
System (Life Technologies). To control for RNA input,
peptidylprolyl isomeraseA levelsweremeasuredand target
mRNA expressionwas quantified using theCt method
(Schmittgen & Livak, 2008).
Statistical analyses
Descriptive statistics were produced for all data sets to
check fornormaldistribution (accepted ifP>0.05)usinga
Kolmogorov–Smirnov test.All data arepresented asmeans
± SEM. Subject physical characteristics were measured
via Student’s t-test and all other data sets were analysed
by repeated measures two-way ANOVA with a Bonferroni
correction using Prism v. 5 (GraphPad Software, La Jolla,
CA, USA). Correlations were assessed using Pearson’s
product moment correlation coefficient. The α level of
significance was set at P < 0.05.
Results
Subject characteristics
Subject baseline characteristics are shown in Table 1. The
significantly different physical characteristics were skeletal
muscle index (SMI), TFFM, 1-RM and MVC, which were
lower inO vs. Y subjects. AdditionallyO subjects had lower
circulating concentrations of testosterone and insulin-like
growth factor 1 (IGF-1), with no difference in myo-
statin levels. Only young subjects significantly increased
testosterone levels after the first bout of RET. Monitoring
of habitual dietary and activity behaviours revealed that
during the study older subjects registered on average less
activity counts per day and tended to have a decreased
protein intake (g (kg fat free mass (FFM))–1 day−1).
Muscle strength, mass and architecture
Over the training programme (Fig. 1) Y and O subjects
both increased 1-RM, Y achieving 35.0 ± 4%, P < 0.01
andO25.3± 3%,P< 0.01 after 6weekswith no difference
in the increase between groups (Fig. 2A). In contrast,
measures of MVC showed increases in Y only, with the
average change across all joint angles at 6weeks of 21± 5%
(P < 0.01) in Y and 6.3 ± 3% in O (NS) (Fig. 2B).
However, taking the peak performance at any given angle
for each individual (since optimal performance may vary
by angle within individual subjects), both Y andO showed
increased MVC (Y, 36.2 ± 5%, P < 0.001; O 16.4 ± 4%,
P < 0.05). TFFM measured by DXA showed that in
addition to having greater mass before and after RET, only
Y increased TFFM after the 6-week training programme,
from 6023 ± 284 to 6249 ± 315 g (P < 0.05) vs. O,
5156 ± 198 to 5218 ± 194 g (Fig. 2C). Temporal changes
in VL architecture measured via ultrasound revealed by
3 weeks, RET induced increases in Y muscle thickness
(MT, from 2.46± 0.1 to 2.66± 0.1 cm, P< 0.01; Fig. 2D),
pennation angle (θ, from18.6±1 to 19.7±1deg,P<0.01;
Fig. 2E) and fibre length (Lf, from 7.8 ± 0.4 to 8.2 ± 9
0.4 cm, P< 0.01; Fig. 2F). By 6 weeks of training there was
no further increase in any of these variables (2.72± 0.1 cm,
20.2± 1 deg and 8.3± 0.4 cm,MT, θ and Lf, respectively).
In contrast, O did not significantly increase any of these
measures over the 6 weeks: MT, 2.0 ± 0.1 to 2.1 ± 0.1 and
2.1± 0.1 cm; θ, 15.6± 0.6 to 16.3± 0.8 and 16.4± 0.8 deg;
and Lf, 7.3 ± 0.1 to 7.33 ± 0.1 and 7.36 ± 0.1 cm at 0, 3
and 6weeks, respectively. The untrained (UT) legs showed
no changes in muscle architecture from baseline over the
6 weeks.
Muscle RNA, DNA and protein concentrations
There were no changes in the alkali soluble protein (ASP)
per wet weight muscle (μg mg−1) in trained (T) legs of
either group throughout the 6-week RETperiod, although
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Table 1. Subject characteristics
Young Old
Age (years) 23 ± 1 69 ± 1∗
Height (m) 1.80 ± 0.02 1.75 ± 0.02
Weight (kg) 76 ± 3 80 ± 3
BMI (kg m−2) 23.6 ± 1 25.8 ± 1
FFM (kg) 62 ± 2 59 ± 2
ALM (kg) 27.7 ± 1 25.2 ± 1
ALM/h2 (ALM kg m−2) 8.5 ± 0.2 8.1 ± 0.1
SMI 33 ± 1 29 ± 1∗
TFFM (kg) 6.0 ± 0.2 5.2 ± 2∗
1-RM (N) 546 ± 31 352 ± 31∗
MVC (N m) 232 ± 20 172 ± 15∗
Activity counts 72,584 ± 5746 52,445 ± 7462∗
MET (min day−1)
METs < 1.5 932 ± 65 932 ± 18
1.5 METs < 3 231 ± 32 314 ± 94
3 METs < 6 150 ± 30 149 ± 32
6 METs < 10.2 3 ± 1 4 ± 1
10.2 METs 1.3 ± 0.4 0.9 ± 0.4
Protein (g (kg FFM)−1 day−1) 1.73 ± 0.19 1.37 ± 0.09
Hormones Rest Acute RET Rest Acute RET
Testosterone (ng dl−1) 367 ± 19∗ 394 ± 20∗† 274 ± 19 276 ± 18
Myostatin (pg ml−1) 4563 ± 403 4859 ± 450 3781 ± 373 3798 ± 424
IGF1 (ng ml−1) 155 ± 16∗ 158 ± 16∗ 84 ± 9 80 ± 9
Values are means ± SEM. ∗Significantly different between young and old subjects P < 0.05, †significantly different frm rest P < 0.05.
1-RM, one repetition maximum; ALM, appendicular lean mass; FFM, fat-free mass; MET, metabolic equivalent; MVC, maximum
voluntary contraction; SMI, skeletal muscle index; TFFM, thigh fat free mass.
Y had greater ASP at 3 weeks than O (613.5 ± 25 vs.
480.5 ± 33, P < 0.05; Fig. 3A). The ratio of ASP:DNA
(μg μg−1), a measure of cell size, displayed a trend to
increase by 6 weeks (88 ± 8 to 103 ± 5, P = 0.1),
whilst O showed no change at any time point (Fig. 3D).
RNA content (μg mg−1) increased in Y only at 3 weeks
(2.75± 0.2 to 3.91± 0.2,P< 0.01) with a trend to increase
at 6 weeks (3.38 ± 0.1, P = 0.1), whilst there was no
change in RNA content in O (Fig. 3B). The DNA content
(μg (mg wet weight of muscle)−1; Fig. 3C) did not change
in either group over the training period; however, the ratio
of μg RNA:μg DNA a reflection of ribosomal capacity
per unit DNA, increased in Y at 3 weeks (0.47 ± 0.05 to
0.62 ± 0.05, P < 0.05) and remained increased at 6 weeks
(0.64± 0.03, P< 0.01, Fig. 3E). In contrast to Y, there was
no change in RNA:DNA in O (0.53 ± 0.05 to 0.57 ± 0.05
and 0.58 ± 0.05, NS, at 0, 3 and 6 weeks, respectively).
Finally the ratio of RNA:ASP (μg mg−1), primarily a
measure of ribosomal capacity (Laurent et al. 1978;
Waterlow et al. 1978), was elevated at 3 weeks (5.0 ± 0.3
to 6.0± 0.3, P= 0.06) and increased at 6 weeks (6.1± 0.3,
P < 0.05) with no change in O (4.9 ± 0.5 to 5.7 ± 0.4
and 5.6 ± 0.5, NS) at 0, 3 and 6 weeks, respectively
(Fig. 3F).
Muscle protein synthesis, absolute and fractional
growth rates
Therewas no difference inmuscle protein synthesis (MPS)
in the UT leg between Y and O; 1.35 ± 0.08% day−1
and 1.34 ± 0.09% day−1, respectively. With the onset
of RET, only Y increased MPS from 0 to 3 weeks
(1.6 ± 0.01% day−1, P < 0.05 vs. O, 1.49 ± 0.08% day−1,
NS); however, by 6 weeks MPS was no longer increased
in Y (1.45 ± 0.05% day−1) and remained unchanged in
O (1.39 ± 0.1% day−1; Fig. 4A). Absolute synthetic rate
(ASR; g d−1) was increased in the T leg only in the Y
group over the 6 weeks (8.1 ± 0.1 to 9.3 ± 0.7; P < 0.05),
with similar findings of increased fractional growth rate
(FGR;%day−1) in Y only (–0.002± 0.016 to 0.086± 0.02,
P< 0.001; Fig. 4B and C). In contrast there was no change
in absolute breakdown rate (ABR; g d−1) observed with
either group over the 6-week RET period (Y, 8.5 ± 0.6 to
8.1 ± 0.8; O, 6.6 ± 0.5 to 7.3 ± 0.7 g; both NS; Fig. 4D).
Intramuscular mRNA expression and signalling
There were no differences between Y and O in the base-
line expression of any of the genes measured (Table 2).
However, 60–90 min after the first exercise bout Y showed
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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increases in c-MYC expression (P < 0.05), indicating
activation of ribosomal transcription (P < 0.05).
Additionally, only O increased MAFBx and RPS26
60–90 min after the first exercise bout in T legs
compared to UT (P < 0.05) and showed a trend for
increase with MuRF-1 (P = 0.06). Muscle anabolic
signalling 60–90 min (Fig. 5) after the first exercise bout
showed there were significant increases compared to UT
in phosphorylation of P70SK1Thr389, RPS6ser240/244 and
ERKThr202/Tyr204. Further, only Y increased total levels of
c-MYC and TIF1a after the first exercise bout, whilst O
increased phosphorylation of RPS6ser240/244 after the first
exercise bout and MuRF-1 60–90 min after RE at 3 weeks.
Correlations
RNA:DNA was not correlated with MT in the UT state;
however, at 3weeksMTwas correlatedwith theRNA:DNA
content being driven primarily by changes in the young
subjects (Fig. 6A), although RNA:DNAwas not correlated
with TFFM at 6 weeks (Fig. 6B). The change in P70S6K1
phosphorylation showed a trend for association with the
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change in TFFM across all subjects (P = 0.07) (Fig. 6D),
although it was not correlated with the change in MT
at 3 weeks (Fig. 6C). The acute RE-induced levels of
testosterone were correlated with the change in MT at
3 weeks (Fig. 6E) and this change in acute testosterone
levels was correlated with the change in TFFM at 6 weeks
(Fig. 6F). Protein intake across all subjects showed a trend
for correlation with the early changes in MT at 3 weeks
(Fig. 6G, P = 0.07), although it was not correlated with
the change in TFFM at 6 weeks (Fig. 6H).
Discussion
There has been a great deal of interest in recent years
in uncovering the mechanisms underlying hypertrophic
adaptations to exercise, and how these adaptations are
influenced by age. Yet much of this information has
been largely derived from ‘acute’ metabolic andmolecular
studies, which may not accurately reflect the true chronic
adaptation. Therefore this study used novel D2O tracer
techniques to investigate the temporal effects of RET on
longer term MPS, hypertrophy and strength adaptations
in groups of young and older individuals. This provides
the first evidence that blunted hypertrophic responses in
older individuals are underpinned by chronic deficits in
MPS reflecting blunted ribosomal biogenesis and trans-
lational efficiency and lower anabolic hormone profiles,
thus highlighting the multifactorial nature of the blunted
hypertrophic responses.
Whether ageing impairs hypertrophic responses to
RET remains contentious. For instance, RET-induced
hypertrophy of thigh muscles has been shown to be
equal (Ha¨kkinen et al. 1998b; Mayhew et al. 2009) or
impaired (Kosek et al. 2006; Greig et al. 2011; Mero
et al. 2013) with age. In the present study, we utilized a
6-week-long progressive RET training programme during
which we detected no significant increases in either TFFM
(DXA) or hypertrophy-related alterations in architecture
(ultrasound) in old individuals indicative of blunted
RET-induced hypertrophy in thigh muscles, which are
among the muscle groups more profoundly affected by
ageing (Janssen et al. 2000) and most important for
stability and preventing falls. Similarly, studies of an equal
time period in older males have reported no increases in
total lean body mass (Fragala et al. 2014) and similarly
no change in VL muscle architecture or TFFM after
6 weeks RET (Scanlon et al. 2014). Indeed, even with
long-term (20 weeks) progressive RET, muscle gains are
subtle, e.g. 1 kg in lean mass (Peterson et al. 2011), and
diminished compared to younger counterparts (Phillips
et al. 2012). Intriguingly, these data reflect the notion
that RET-induced hypertrophy occurs rapidly (first 3–4
weeks), diminishing thereafter (Brook et al. 2015). As
such, long-term stimuli are neither a prerequisite for
muscle growth nor likely to significantly alter age-related
blunted responses. Thus, our present data support the pre-
vailing notion of impaired hypertrophic responses to RET
with ageing, although, with time, old individuals will see
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benefits in whole body strength (Peterson et al. 2010), and
noticeable increases in1-RMandMVCwere seenhere after
6 weeks. Improvements in strength, whether dynamic or
static, with little or no increases in muscle mass essentially
derive from improvements in ‘muscle quality’. Whilst
improvements in muscle quality are generally attributed
to increased neural activity (Ha¨kkinen et al. 1998a; Tracy
et al. 1999), improved strength may occur by many other
modifiable aspects of muscle contraction (Fragala et al.
2015) improving physical function (Fiatarone et al. 1994;
Fragala et al. 2014) and ultimately quality of life (Masel
et al. 2009).
Skeletal muscle mass is controlled by the balance
between MPS and MPB. Acute amino acid stable iso-
tope tracer studies have shown no difference in fasting
or resting MPS or MPB as a result of ageing (Volpi et al.
2001). The present study provides the first report of longer
term MPS (over weeks) in young and older individuals in
the same study under ‘basal’, conditions. The longer term
D2O-derived measures represent free-living rates of MPS
incorporating integrated responses to habitual nutritional
intake and physical activity behaviours in young and older
recruits. Since loss of muscle mass beyond 70 years
of age occurs at a rate of 0.5–1% year−1 (and assuming
no changes in MPB), daily MPS would only need to be
decreased 0.0015–0.003% day−1 to account for such a
loss. Thus, it is unsurprising that cumulative MPS (even
over weeks) was not detectably modified by age. Instead,
older muscle demonstrates blunted responses to anabolic
stimuli key to regulatingmuscle homeostasis, i.e. nutrition
and physical activity (Cuthbertson et al. 2005; Kumar
et al. 2009b). For example, the RET-induced stimulation
of MPS is attenuated (< 6 h) after a bout of RE in older
vs. young subjects (Kumar et al. 2009b). A similar result
has been reported for responses to RET at 3, 6 and 24 h
(Fry et al. 2011) with others also showing reduced rates
in older individuals being sustained 24 h after a bout of
RET (Mayhew et al. 2009). This study shows that findings
from the acute setting translate into longer term deficits
in MPS in the elderly, a notion that would not necessarily
be obvious given that acute bouts of exercise (on which
the foundation of anabolic resistance has been built) do
not correlate to longer term hypertrophy (Mitchell et al.
2014). Finally, it is noteworthy that measures of MPS
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Table 2. Muscle mRNA expression
Basal 3 weeks 6 weeks
Rest Acute RET Rest Acute RET Rest Acute RET
C-MYC
5’-GGTAGTGGAAAACCAGCAGCC-3’ Y 1.00 ± 0.4 4.01 ± 1.6∗ 1.52 ± 0.6 2.45 ± 0.6 1.16 ± 0.3 2.49 ± 0.5
5’-TCTCCTCCTCGTCGCAGTA-3’ O 0.75 ± 0.3 1.89 ± 0.8 0.66 ± 0.2 2.95 ± 0.9 0.73 ± 0.2 2.73 ± 0.7
POL1RA
5’-CCTCAAGGTATCGCCCAGTC-3’ Y 1.00 ± 0.1 1.41 ± 0.2 1.25 ± 0.2 1.49 ± 0.2 1.41 ± 0.2 1.03 ± 0.2
5’-GGCAACTTCTGTTCTTGGGC-3’ O 1.21 ± 0.2 1.36 ± 0.2 0.95 ± 0.1 0.97 ± 0.2 0.81 ± 0.1 1.41 ± 0.3
POL1RB
5’-TACTGTGCAACTTGGGGGTC-3’ Y 1.00 ± 0.2 1.62 ± 0.4 1.93 ± 0.4 1.39 ± 0.3 1.71 ± 0.3 1.39 ± 0.2
5’-GAGAATCTGCGATGCCTGGA-3’ O 1.24 ± 0.4 1.22 ± 0.3 1.47 ± 0.5 1.69 ± 0.5 1.33 ± 0.3 2.60 ± 0.6
TAF1A
5’-AGGTTTAGCGCCTGCTCATA-3’ Y 1.00 ± 0.3 1.62 ± 0.4 1.47 ± 0.3 0.84 ± 0.2 1.21 ± 0.1 0.69 ± 0.1
5’-CTGAAATCACTCATACCCGCCT-3’ O 1.14 ± 0.3 1.28 ± 0.4 1.27 ± 0.3 1.44 ± 0.3 1.55 ± 0.6 2.01 ± 0.6
TIF1A
5’-CATTTTGTGCCTCCCCGAGT Y 1.00 ± 0.3 1.43 ± 0.5 1.61 ± 0.5 0.87 ± 0.3 1.61 ± 0.3 0.98 ± 0.3
5’-GTATTGGCATGAGAAACCACGG-3’ O 1.29 ± 0.4 1.25 ± 0.5 1.04 ± 0.2 1.18 ± 0.3 1.49 ± 0.4 1.57 ± 0.4
UBF
5’-AAGAAGCCTCCCATGAACGG-3’ Y 1.00 ± 0.2 1.59 ± 0.4 1.34 ± 0.2 1.77 ± 0.4 1.51 ± 0.2 1.79 ± 0.6
5’-CGGCCAGCTTTTTGTAGTGC-3’ O 1.42 ± 0.4 2.00 ± 0.6 1.98 ± 0.6 0.69 ± 0.2 1.58 ± 0.3 3.03 ± 0.6
MuRF1
5’-GTGTTTGGGGCTCACCAGGC-3’ Y 1.00 ± 0.2 2.86 ± 0.8 0.67 ± 0.1 1.61 ± 0.4 1.22 ± 0.5 1.01 ± 0.4
5’-ACCTGGTGGCTATTCTCCTTGGT-3’ O 1.41 ± 0.3 3.86 ± 1.5 1.01 ± 0.3 1.81 ± 0.5 1.74 ± 0.9 2.43 ± 0.8
MAFbx
5’-CTTTCAACAGACTGGACTTCTCGA-3’ Y 1.00 ± 0.2 2.05 ± 0.4 1.19 ± 0.3 2.07 ± 0.3 1.47 ± 0.2 1.26 ± 0.2
5’-CAGCTCCAACAGCCTTACTACGT-3’ O 1.26 ± 0.2 3.12 ± 0.9∗ 1.20 ± 0.2 2.23 ± 0.7 1.38 ± 0.4 2.12 ± 0.6
20S proteasome
5’-CGTTTTCAACGGAGGTACTA-3’ Y 1.00 ± 0.31 1.31 ± 0.4 1.36 ± 0.3 1.10 ± 0.3 1.41 ± 0.3 1.13 ± 0.2
5’-TCAGCGTAAGACAGTCTCCA-3’ O 1.21 ± 0.22 1.47 ± 0.5 1.18 ± 0.3 1.27 ± 0.3 1.69 ± 0.5 1.94 ± 0.6
Caspase 3
5’-TCCACAGCACCTGGTTATTATTC-3’ Y 1.00 ± 0.3 1.45 ± 0.4 1.38 ± 0.3 1.00 ± 0.2 1.73 ± 0.4 1.52 ± 0.4
5’-GCGTCAAAGGAAAAGGACTC-3’ O 0.79 ± 0.2 0.91 ± 0.3 1.09 ± 0.3 1.27 ± 0.3 1.27 ± 0.4 1.85 ± 0.6
Calpain L
5’-GCCAAGCAGGTGAAC-3’ Y 1.00 ± 0.3 1.81 ± 0.8 1.53 ± 0.4 1.01 ± 0.2 2.35 ± 0.9 0.80 ± 0.2
5’-TGAAGTCTCGGAATGACATC-3’ O 1.39 ± 0.3 1.95 ± 0.7 1.82 ± 0.5 2.01 ± 0.6 2.11 ± 0.7 2.55 ± 0.7
RPS5
5’-ATCATCAACAGTGGTCCCCG-3’ Y 1.00 ± 0.3 1.52 ± 0.7 1.24 ± 0.3 1.13 ± 0.3 1.22 ± 0.2 1.18 ± 0.2
5’-AGATGGCCTGGTTCACACG-3’ O 1.42 ± 0.4 1.24 ± 0.4 1.80 ± 1.0 1.05 ± 0.3 1.32 ± 0.4 1.68 ± 0.3
RPSA
5’-CCCTACTGAAGACTGGAGCG-3’ Y 1.00 ± 0.2 1.07 ± 0.2 0.96 ± 0.2 0.78 ± 0.2 0.78 ± 0.1 0.81 ± 0.2
5’-AGAGCCTATGCAAGAACAGCTT-3’ O 0.77 ± 10.1 1.19 ± 0.4 0.75 ± 0.3 0.45 ± 0.1 0.65 ± 0.1 0.76 ± 0.1
RPS26
5’-CGAGCGTCTTCGATGCCTAT-3’ Y 1.00 ± 0.1 0.97 ± 0.1 1.11 ± 0.1 0.97 ± 0.1 1.01 ± 0.1 0.87 ± 0.1
5’-CAGGTCTAAATCGGGGTGGG-3’ O 1.00 ± 0.1 1.48 ± 0.2∗ 1.16 ± 0.1 1.32 ± 0.2 1.04 ± 0.1 1.17 ± 0.2
RPS3
5’-GGAAGTTTGTCGCTGATGGC-3’ Y 1.00 ± 0.1 1.23 ± 0.2 1.19 ± 0.2 1.27 ± 0.2 1.17 ± 0.1 0.92 ± 0.1
5’-ACATTCTGTGTTCTGGTGGCT-3’ O 1.22 ± 0.3 1.49 ± 0.3 1.26 ± 0.2 1.35 ± 0.2 1.21 ± 0.2 1.82 ± 0.3
RPL13A
5’-TAAACAGGTACTGCTGGGCCG Y 1.00 ± 0.2 1.31 ± 0.2 1.52 ± 0.2 1.19 ± 0.2 1.37 ± 0.1 1.11 ± 0.2
5’-CTCGGGAAGGGTTGGTGTTC O 1.44 ± 0.4 1.31 ± 0.3 1.19 ± 0.3 1.31 ± 0.4 1.11 ± 0.3 1.53 ± 0.3
(Continued)
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Table 2. Continued
Basal 3 weeks 6 weeks
Rest Acute RET Rest Acute RET Rest Acute RET
RPL11
5’-AGGGTCTAAAGGTGCGGGA-3’ Y 1.00 ± 0.2 1.91 ± 0.5 2.19 ± 0.4 1.12 ± 0.3 1.73 ± 0.2 1.09 ± 0.4
5’-AGTCCAGGCCGTAGATACCA-3’ O 1.33 ± 0.4 1.55 ± 0.5 1.05 ± 0.3 1.31 ± 0.4 1.15 ± 0.3 1.95 ± 0.4
Androgen receptor
5’-TCAGCATTATTCCAGTGGATG-3’ Y 1.00 ± 0.2 0.99 ± 0.2 0.99 ± 0.3 1.04 ± 0.2 1.82 ± 0.4 0.83 ± 0.1
5’-GGAGCTTGGTGAGCTGGTAG-3’ O 0.88 ± 0.2 1.15 ± 0.3 1.06 ± 0.3 1.45 ± 0.3 0.90 ± 0.2 1.21 ± 0.3
Myostatin
5’-GCTGCGCCTGGAAACAGCTC-3’ Y 1.00 ± 0.2 1.42 ± 0.4 2.08 ± 0.5 1.17 ± 0.4 2.74 ± 1.1 1.39 ± 0.3
5’-ATCAGTTCCCGGAGTGGAGGC-3’ O 2.32 ± 0.5 1.96 ± 0.6 2.78 ± 0.6 2.01 ± 0.3 2.58 ± 0.9 1.72 ± 0.3
Data expressed as fold change from young (means ± SEM). Forward primer is the upper sequence and reverse primer lower sequence.
∗Significantly different from UT leg at that time point. MAFbx, muscle atrophy F-box; MuRF1, muscle RING finger 1; RPL, ribosomal
protein large; RPS, ribosomal protein small; TAF1A, TBP-associated factor 1A; TIF1a, transcription initiation factor 1; UBF, upstream
binding factor 1. POL1RA, RNA polymerase 1 subunit A; POL1RB, RNA polymerase 1 subunit B.
using D2O incorporate behavioural activities outside of
study control, i.e. habitual physical activity and dietary
behaviours. Although the older subjects registered fewer
activity counts in this study, they weremore active than an
average population of their age group (Schrack et al. 2014)
and additionally spent equal time in physical activities
requiring the same level of metabolic equivalent (MET)
as younger recruits. Studies where drastic decrements in
activity are enforcedhavenegative effects onmuscle (Olsen
et al. 2008; Krogh-Madsen et al. 2010; Breen et al. 2013);
in contrast, our old subjects are likely to maintain lower
levels of activity (Dipietro, 2001) in which we are unaware
of any evidence that habitual ‘inactivity’ has deleterious
consequences upon RET-induced muscle hypertrophy.
Habitual behaviours may differ both among individuals
andacross age. It cannot thereforebe entirely ruledout that
slight age-related behavioural differences could contribute
to anabolic resistance, in both acute experimental settings
and the chronic accumulationof these over time.However,
intervention studies would be needed to resolve these
interesting concepts and may warrant further study.
One of the key facets regulating MPS is ribosomal
activity (so called ‘translational efficiency’). The acute
simulation of MPS by RE relies upon increased trans-
lational efficiency (Chesley et al. 1992; Drummond et al.
2009). Acute RE (and nutrient interactions) converge on
the pleiotropic protein kinase mTORc1, with subsequent
downstream signalling enhancing translation initiation
and elongation, a pathway essential to acute RE-induced
stimulation of MPS (Drummond et al. 2009). We and
others have previously shown that P70S6K1 signalling
after RE is blunted in older individuals (Kumar et al.
2009b; Fry et al. 2011). In the present study we were able
to look at the temporal activation of mTORc1 signalling
in young and older individuals. In doing so, we found
that P70S6K1 increased only after the first bout of exercise
and that this was only observed in the younger group,
while RPS6 phosphorylation was increased in both young
and older individuals, again only after the first bout. The
increase in P70S6K1 activation displayed a trend to be
correlated with the increase in TFFM, adding to previous
associations betweenP70S6K1activation andhypertrophy
(Baar & Esser, 1999) and dysregulation in MPS responses
with age (Kumar et al. 2009a; Fry et al. 2011). Additionally,
these findings are in agreementwith the notion that hyper-
trophy occurs early and also that RE-trained individuals
display attenuations in P70S6K1 (Coffey et al. 2006;
Gonzalez et al. 2015). The absolute onset of attenuated
signalling responses is unclear, and acute stimulation
of anabolic signalling responses may remain up until
before the 3-week time point, with the duration and
pattern of these responses unknown. However, early
transcriptional responses are quickly modifiable (Murton
et al. 2014) and activation of key signalling proteins is
attenuated with repeated exercise stimulus (Ogasawara
et al. 2013). This suggests that with prolonged training
these signalling pathways become refractory to loading
accounting for reduced rates of hypertrophy with training
progression. Nonetheless, while age-related blunting was
seen in P70S6K1, this was not a uniform response across
signals following the first exercise bout, suggesting that
blunted translational efficiency is one aspect of, but
perhaps not the entire explanation for, blunted muscle
hypertrophy that is seen in older individuals.
In addition to increasing translational efficiency,
prolonged muscle overload produces increases in RNA
content and therefore capacity for protein synthesis
(Laurent & Sparrow, 1977; Kirby et al. 2015), a subject
matter which has been the of interest in renewed research
(Nader et al. 2014; Figueiredo et al. 2015, 2016; Kirby et al.
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Figure 5. Intramuscular signalling
Relative change compared with UT in mTORc1Ser2448 (A), p70S6K1Thr389 (B), rps6ser240/244 (C), ERK1/2Thr202Tyr204
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∗Significantly different from UT, P < 0.05. UT, untrained.
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2015; Stec et al. 2015;West et al. 2016). Indices of synthetic
capacity (RNA:protein andRNA:DNAratios; Laurent et al.
1978; Smith et al. 2011) increased early into RET in young
individuals, plateauing by 3 weeks RET, and furthermore
these responses were blunted with age. Additionally, with
3 weeks RET, MT was correlated with indices of synthetic
capacity (RNA:DNA), which was not evident in the UT
state, suggesting early hypertrophy is supported by early
increases in synthetic capacity. To gain insight into the
molecular mechanism regulating ribosomal biogenesis,
upstream signalling pathways controlling ribosomal DNA
(rDNA) transcription such as c-MYC, which controls
many aspects of cell growth and ribosomal biogenesis,
were investigated. c-MYC gene expression and protein
abundance were increased in young individuals but were
blunted with age, which is in line with previous reports
showing that markers of ribosomal biogenesis are reduced
in older adults 24 h after a bout of RET and suggesting
rDNA transcription is compromised with age (Stec et al.
2015). Successful rDNA transcription requires multiple
transcription factors, including UBF and TIF1a, with
their activities controlled by many phosphorylation sites
and upstream signalling pathways (reviewed in Kusnadi
et al. 2015). However, similar to previous studies, TIF1a
increased only in young individuals ostensibly driving
rDNA transcription (Stec et al. 2015a). Together, our data
point to impairments in the regulation of translational
capacity in addition to the aforementioned translational
efficiency.
Beyond mechano-sensitive pathways, muscle mass and
RET-induced muscle hypertrophy are also regulated by
hormones, e.g. testosterone, IGF-1,myostatin, etc. (Bhasin
et al. 1996; Barton-Davis et al. 1998; Whittemore et al.
2003; Kvorning et al. 2006). Ageing negatively regulates the
‘anabolic’ environment with declining endocrine function
resulting in chronic low levels of many hormones such
testosterone and IGF-1 (Leifke et al. 2000). Whilst myo-
statin negatively regulates muscle mass, growth hormone,
IGF-1 and testosterone, whose levels when enhanced, or
restored in older age, act as powerful anabolic agents
and can substantially increase muscle mass (Bhasin et al.
2001; Sattler et al. 2009; Neto et al. 2015). Compromised
hormonal balances with age are therefore likely to impair
exercise adaptations, yet the precise influence in early
exercise adaptations isunclear.Uponexaminationof these,
we found no difference in myostatin between young and
old individuals, and this was not acutely affected by RE.
Similarly, sensitive liquid chromatography tandem mass
spectrometry methods have demonstrated that in males,
serummyostatin acts as a homeostatic regulator of muscle
mass rather than a cause of sarcopenia (Bergen et al.
2015), further adding to oppose evidence that myostatin
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Figure 6. Correlations
Correlations between RNA:DNA at 3 weeks and MT at 3 weeks (A), RNA:DNA at 6 weeks and TFFM at 6 weeks
(B), the increase in P70S6K1T389 after first RET bout and the percentage change in MT at 3 weeks (C), the increase
in P70S6K1T389 after first RET bout and the percentage change in TFFM at 6 weeks (D), testosterone after first
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MT, muscle thickness; RET, resistance exercise trained; TFFM, thigh fat free mass.
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is implicated in the age relate muscle mass loss (Yarasheski
et al. 2002). Circulating levels of many anabolic hormones
decrease with age, and we found significantly lower
circulating levels of testosterone and IGF-1; moreover
only younger individuals increased testosterone after the
first bout of RE. Prevention of testosterone production
in young males through provision of a GnRH inhibitor
has been shown to prevent RET-induced hypertrophy
(Kvorning et al. 2006), whilst blunted hypertrophy has
previously been reported in older men displaying reduced
RE-induced increases in testosterone (Kraemer et al.
1999). This highlights impaired endocrine response in
older age, yet whether a lack of acute hormonal responses
contributes to diminished hypertrophy is unclear. Acute
RE-induced increase in testosterone was correlated with
the increase in TFFM, and this was strongest in Y where
testosterone had increased. Further, whole body RET
in older subjects with low testosterone shows minimal
(+0.6%) changes in fat-freemass (FFM)after 12months
RET (Hildreth et al. 2013) while no change in FFM
occurred in elderly males with low normal testosterone
after 24 weeks RET (Kvorning et al. 2013). Both studies
showed greater improvements in FFM when testosterone
supplementation and RET were combined. Together with
our data this demonstrates that chronic low levels of
testosterone and possibly a lack of acute increases may
play a significant role in attenuated hypertrophy with age.
In addition to transient increases inMPSwith RE,MPB
is also increased (Phillips et al. 1997), probably to remove
old or damaged proteins. The protein ligasesmuscle RING
finger 1 (MuRF1) andmuscle atrophy F-box (MAFbx) are
markers of ubiquitin proteasome pathway activity, which
is thought to be predominant in acute RE responses (Fry
et al. 2013). However, after a single bout of exercise,
expression of MuRF-1 and or MAFbx have shown no
change (Greig et al. 2011; Fry et al. 2013), equal increases
(Fry et al. 2013; Stefanetti et al. 2014) or a greater increase
with age (Raue et al. 2007) and thereforemuchuncertainty
exists within the literature.We found an initial increases in
MAFbx expression and a tendency towards greaterMuRf1
expression that only occurred in our older volunteers. Our
measures were made 60–90 min after RET, in comparison
to  2 h in these other studies and so our results may
highlight key early differences in MPB. Measures of the
FBR 24 h after RET have shown no difference between
young and old; however, whether there are any earlier
differences is unknown (Fry et al. 2013). Nonetheless,
despite greater initial increases in MPB markers with
age, there was no increase in ABR, highlighting that lack
of muscle hypertrophy in older age is likely to be pre-
dominantly driven by blunted MPS responses rather than
increases in MPB.
We also need to acknowledge limitations within our
study. The data are limited to changes between three time
points and each individual’s response may temporally
differ across the study period. Further, biopsy timings
within this study reflect acute responses to RE and
how these adapt over time, and do not demonstrate
how resting levels of gene and protein expression
may change with training. Additionally, although D2O
permits long-term measures of MPS, these are highly
integrated, incorporating everyday habitual regimes with
RE responses. In this study, subjects followed their usual
habitual physical activity (potential impacts as previously
discussed) and diet, which we recorded. In this study,
older subjects tended, i.e. non-significantly, to consume
lower protein levels than younger subjects, which could
theoretically impact our findings since acute protein
feeding coupled to RET enhances MPS (Bukhari et al.
2015). That said, results of protein supplementation
with RET in ageing have been mixed, i.e. shown to
enhance (Esmarck et al. 2001) or not affect (Verdijk
et al. 2009) muscle hypertrophy, while the effects of
habitual protein feeding behaviours in this context of
RET, ageing and hypertrophy remain poorly defined. That
said, since protein intake was not correlated with muscle
mass changes in young, old or all subjects combined in
our study, any slight differences in protein intake are
highly unlikely to be responsible for the observed anabolic
resistance. In conclusion we have shown that age-related
deficits in anabolic responses to RET are multifactorial,
a product of attenuations in translational efficacy and
capacity and unfavourable hormone profiles, culminating
in reduced MPS and compromised overall hypertrophy.
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